23.10.2024 • NewsAvantiuminvestment

Avantium Opens Biobased FDCA Plant in the Netherlands

Dutch renewables specialist Avantium has officially opened its FDCA (furandicarboxylic acid) flagship plant in Delfzijl, the Netherlands. Plans for what was said to be the world's first commercial-scale production plant for FDCA were first announced in December 2021.

In the plant, Avantium will produce 5,000 t of FDCA, the essential building block for 100% plant-based and circular plastic PEF (polyethylene furanoate), known under the brand name Releaf. The company’s material has versatile applications including bottles, packaging, films, and textiles.

Tom van Aken, Avantium’s CEO, said: “Our new FDCA plant embodies our commitment to innovation and sustainability. We are excited to lead the way in producing Releaf, a material that offers a viable alternative to traditional petroleum-based plastics. This plant is not just a testament to our technological advancements but also to our dedication to creating long-term, sustainable value for all our stakeholders.”

Avantium also plans to accelerate the rollout of its FDCA/PEF licensing strategy.

© Avantium
© Avantium

Company

Logo:

Avantium

Zekeringstraat 29
1014 BV Amsterdam
Netherlands

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.